[New expectations in the control of hepatitis B virus infection].
Ruiz Moreno
M
M
Servicio de Pediatría, Fundación Jiménez Díaz, Universidad Autónoma, Madrid.
D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D015415:Biomarkers; D002353:Carrier State / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D006509:Hepatitis B / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007370:Interferon Type I / Q000627:therapeutic use*; D010865:Pilot Projects; D011994:Recombinant Proteins; D014740:Vidarabine / Q000627:therapeutic use
D015415:Biomarkers; D007370:Interferon Type I; D011994:Recombinant Proteins; D014740:Vidarabine; D000212:Acyclovir
Nuevas expectativas en el control de la infección por virus B de la hepatitis.